Tegoprazan
Tegoprazan is a potent and selective oral inhibitor of gastric H+/K+-ATPase, demonstrating in vitro IC50 values of 0.29-0.52 μM across species. It is utilized in research on gastric acid secretion, motility, and related gastrointestinal disorders, with applications in both in vitro enzymatic assays and in vivo pharmacological studies.
Product Specifications
CAS Number
942195-55-3
Product Name Alternative
Acid, inhibit, Inhibitor, gastric, H+/K+-ATPase, secretion, pentagastrin, Tegoprazan, Proton Pump, Protonpump, Proton pump
Field of Research
Pharmacology & Drug Discovery
Purity
98.22% (May vary between batches)
Solubility
DMSO:22.5 mg/mL (58.08 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.16 mM)
Smiles
CN (C) C (=O) c1cc (O[C@H]2CCOc3cc (F) cc (F) c23) c2[nH]c (C) nc2c1
Molecular Formula
C20H19F2N3O3
Molecular Weight
387.38
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
RGD1306625 CRISPR All-in-one AAV vector set (with saCas9)(Rat)